Pharma
QuantHealth cofounder and CEO Orr Inbar discusses how using artificial intelligence for clinical trial simulations can help solve challenges often seen by patients, researchers and the pharmaceutical industry when studying a new drug.
Sanofi head of organization capability and transformation, Felix Lee, discusses how the pharma giant leverages digital therapeutics company DarioHealth to complement its drug offerings and enhance patient care and self-management.
HIMSS24
Emmanuel Bilbault, cofounder and CEO of POSOS, says the company's AI-driven international drug database's use of medication codes enables it to cross-reference EHR data and tailor prescriptions to meet a patient's specific needs.
Continuous Precision Medicine can help confirm a patient's pain medication intake so providers can better manage preventable issues, says the company's CEO and cofounder Steven Walther. However, accurate data is vital to ensuring validity.
HIMSS24
Dr. Colin Banas, CMO at DrFirst, discusses the company's medication adherence product. It uses AI to send texts that educate patients about medications and provides coupons and co-pay-assistance program information, if cost is an issue.
HIMSS24
The founder and president of Medonations, a Lebanese medication company, talks about the aftermath of the 2020 Beirut explosion and her medication-access relief efforts following the disaster.
European pharmacy experts, including leaders from Cleveland Clinic London and other organizations discuss Project Asclepius, a collaborative effort for digitizing pharmacy operations.
Ankit Gupta, Bicycle Health CEO and founder, discusses how the company helps formerly incarcerated individuals access buprenorphine monthly injections for opioid use disorder via the Federal Bureau of Prisons and residential reentry centers.
The offering will give patients with diabetes, migraines and obesity access to care providers and home delivery of Lilly medications via third-party vendors.
Naomi Fried, founder and CEO of PharmStars, discusses the company's fifth cohort focused on solving challenges in therapeutic delivery and the 11 startups graduated from its accelerator program, including Cellular Vehicles and ZiO Health.